What is the current Price Target for the Aerovate Therapeutics Inc stock?

The average Aerovate Therapeutics Inc target price is $18.36. This is 53.00% higher than the current stock price. The highest price target is 145.00%, the lowest is 17.83%. 7 Analysts have issued a price target Aerovate Therapeutics Inc 2026 .

How high will the Aerovate Therapeutics Inc stock rise?

No reliable answer can be given as to how high the Aerovate Therapeutics Inc stock will rise. The performance of stocks, including the Aerovate Therapeutics Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Aerovate Therapeutics Inc stock today?

The performance of Aerovate Therapeutics Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Aerovate Therapeutics Inc stock fall?

The decline in Aerovate Therapeutics Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Aerovate Therapeutics Inc Forecast, price target & analysts

$12.00

4.53%

Nasdaq, Fri, Nov 21 2025

ISIN

US0080641071

Symbol

AVTE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Aerovate Therapeutics Inc Target price 2025 - Analyst rating & recommendation

Aerovate Therapeutics Inc Classifications & Recommendation:

Buy

92%

Hold

Aerovate Therapeutics Inc Price Target

Target Price	$18.36
Price	$12.00
Potential	53.00% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Aerovate Therapeutics Inc 2026 . The average Aerovate Therapeutics Inc target price is $18.36. This is 53.00% register free of charge higher than the current stock price. The highest price target is $29.40 145.00% register free of charge , the lowest is $14.14 17.83% register free of charge .
	A rating was issued by 12 analysts: 11 Analysts recommend Aerovate Therapeutics Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Aerovate Therapeutics Inc stock has an average upside potential 2026 of 53.00% register free of charge . Most analysts recommend the Aerovate Therapeutics Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-85.27	-3.37
	15.06%	96.05%
P/E		negative

8 Analysts have issued a Aerovate Therapeutics Inc forecast for earnings per share. The average Aerovate Therapeutics Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-85.27	15.06%
2025	$-3.37 96.05% Unlock
2026	$-2.25 33.23% Unlock
2027	$-2.04 9.33% Unlock

Current	-6.06	602.19%
2025	-3.56 41.26% Unlock
2026	-5.32 49.44% Unlock
2027	-5.87 10.34% Unlock

Aerovate Therapeutics Inc...

Current Aerovate Therapeutics Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Guggenheim	Locked ➜ Locked	Locked	Nov 18 2025
BTIG	Locked ➜ Locked	Locked	Oct 09 2025
Wedbush	Locked ➜ Locked	Locked	Aug 14 2025
Guggenheim	Locked ➜ Locked	Locked	Jun 16 2025
Wedbush	Locked ➜ Locked	Locked	May 15 2025
Wedbush	Locked ➜ Locked	Locked	May 07 2025

Analyst Rating	Date
Locked Guggenheim: Locked ➜ Locked	Nov 18 2025
Locked BTIG: Locked ➜ Locked	Oct 09 2025
Locked Wedbush: Locked ➜ Locked	Aug 14 2025
Locked Guggenheim: Locked ➜ Locked	Jun 16 2025
Locked Wedbush: Locked ➜ Locked	May 15 2025
Locked Wedbush: Locked ➜ Locked	May 07 2025

Discover more stocks with a high price target

Netflix 1,259.22%

Coinbase Global, Inc. 71.41%

Adidas 58.11%

Novo Nordisk 53.18%

Meta Platforms (Facebook) 50.19%

TUI 49.16%

Rheinmetall 47.68%

BioNTech SE - ADR 45.65%

BYD 44.06%

Adyen 43.87%

Deutsche Telekom 40.33%

Microsoft 36.11%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now